Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ascendis Pharma (DE:A71)
MUNICH:A71
Holding DE:A71?
Track your performance easily
A71 Stock Chart & Stats
Day’s Range€98.5 - €98.5
52-Week Range― - ―
Previous Close€98.5
Volume0.00
Average Volume (3M)N/A
Market Cap
$4.41B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€126.90Price Target Upside28.83% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Ascendis Pharma News
A71 FAQ
What was Ascendis Pharma’s price range in the past 12 months?
Currently, no data Available
What is Ascendis Pharma’s market cap?
Currently, no data Available
When is Ascendis Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Ascendis Pharma’s earnings last quarter?
Currently, no data Available
Is Ascendis Pharma overvalued?
According to Wall Street analysts Ascendis Pharma’s price is currently Undervalued.
Does Ascendis Pharma pay dividends?
Ascendis Pharma does not currently pay dividends.
What is Ascendis Pharma’s EPS estimate?
Ascendis Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ascendis Pharma have?
Currently, no data Available
What happened to Ascendis Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ascendis Pharma?
Among the largest hedge funds holding Ascendis Pharma’s share is RA Capital Management. It holds Ascendis Pharma’s shares valued at 746M.
---
Ascendis Pharma Stock Smart Score
Company Description
Ascendis Pharma
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. Through its TransCon technology, it develops a pipeline of sustained release prodrug therapies including endocrinology product candidates to support the market. The company was founded by Jan Moller Mikkelsen and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.
---
A71 Stock 12 Month Forecast
Average Price Target
€126.90
▲(28.83% Upside)
Technical Analysis
Assembly Biosciences
―
Crispr Therapeutics AG
―
Editas Medicine
―
Fate Therapeutics
―
Ascendis Pharma
―
---